drugset / Trial / NCT00185198

Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)

NCT00185198

Phase 3 Completed 363 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the effect of a testosterone replacement therapy called Testogel in men with PADAM. The effects on body composition (lean, fat and bone) and other symptoms of PADAM and safety will be studied.

Timeline

Start
2004-09
Primary completion
2006-09
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Small molecule 50 mg Topical
Comparator Testosterone Small molecule 75 mg Topical
Comparator Testosterone Small molecule 100 mg Topical

Indications